Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 1Hypopharyngeal Neoplasms 1Carcinoma, Hepatocellular 1Advanced Gastric Cancer 1

Interventions

Cisplatin 14Specimen Handling 6Cetuximab 6Surgical Procedures, Operative 5Radiotherapy, Intensity-Modulated 5Magnetic Resonance Spectroscopy 51,2-diaminocyclohexaneplatinum II citrate 5toripalimab 4Radiotherapy 4Platinum 4Docetaxel 4Celecoxib 4pembrolizumab 3X-Rays 3130-nm albumin-bound paclitaxel 3camrelizumab 2Radiotherapy, Image-Guided 2Radiation 2Paclitaxel 2Fluorouracil 2Chemoradiotherapy 2Carboplatin 2Biopsy 2tislelizumab 1sodium thiosulfate 1sacituzumab govitecan 1nimotuzumab 1nedaplatin 1merphos 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hypopharyngeal Neoplasms × CF regimen × Clear all
NCT01312350 2019-12-09

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Samsung Medical Center

Phase 2 Completed
40 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡